why choose us

First received: May 25, 2023

Clinical Trial: Post-operative Adjuvant Therapy w/wo GammaTile + Systemic Therapy

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Brain Metastases

Study Type: INTERVENTIONAL


Official Title: A Randomized Controlled Trial of Surgical Resection With GammaTile Therapy and Adjuvant Systemic Therapy Compared to Surgical Resection and Adjuvant Systemic Therapy at First Recurrence in Glioblastom

Brief Summary: To compare surgical tumor removal and GammaTile therapy followed by adjuvant systemic therapy (bevacizumab or lomustine) to surgical tumor removal followed by adjuvant systemic therapy (bevacizumab or lomustine) without GammaTile therapy.

Read more